These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16764833)

  • 1. Pharmacokinetic and pharmacodynamic profiles of the novel serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized Sprague-Dawley rats.
    Alfinito PD; Huselton C; Chen X; Deecher DC
    Brain Res; 2006 Jul; 1098(1):71-8. PubMed ID: 16764833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor.
    Deecher DC; Beyer CE; Johnston G; Bray J; Shah S; Abou-Gharbia M; Andree TH
    J Pharmacol Exp Ther; 2006 Aug; 318(2):657-65. PubMed ID: 16675639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of LPM570065, a novel triple reuptake inhibitor, on extracellular serotonin, dopamine and norepinephrine levels in rats.
    Zhang R; Li X; Shi Y; Shao Y; Sun K; Wang A; Sun F; Liu W; Wang D; Jin J; Li Y
    PLoS One; 2014; 9(3):e91775. PubMed ID: 24614602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alleviation of thermoregulatory dysfunction with the new serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized rodent models.
    Deecher DC; Alfinito PD; Leventhal L; Cosmi S; Johnston GH; Merchenthaler I; Winneker R
    Endocrinology; 2007 Mar; 148(3):1376-83. PubMed ID: 17122073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.
    Tian JW; Jiang WL; Zhong Y; Meng Q; Gai Y; Zhu HB; Hou J; Xing Y; Li YX
    Neuroscience; 2011 Nov; 196():124-30. PubMed ID: 21925241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desvenlafaxine succinate ameliorates visceral hypersensitivity but delays solid gastric emptying in rats.
    Dai F; Lei Y; Li S; Song G; Chen JD
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G333-9. PubMed ID: 23764892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desvenlafaxine succinate for major depressive disorder.
    Sproule BA; Hazra M; Pollock BG
    Drugs Today (Barc); 2008 Jul; 44(7):475-87. PubMed ID: 18806899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptoms.
    Seo HJ; Sohi MS; Patkar AA; Masand PS; Pae CU
    Postgrad Med; 2010 Jan; 122(1):125-38. PubMed ID: 20107296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause.
    Pae CU; Park MH; Marks DM; Han C; Patkar AA; Masand PS
    Curr Opin Investig Drugs; 2009 Jan; 10(1):75-90. PubMed ID: 19127490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor.
    Engleman EA; Perry KW; Mayle DA; Wong DT
    Neuropsychopharmacology; 1995 Jul; 12(4):287-95. PubMed ID: 7576005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P; Kehr J; Scheel-Krüger J
    J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
    Koch S; Hemrick-Luecke SK; Thompson LK; Evans DC; Threlkeld PG; Nelson DL; Perry KW; Bymaster FP
    Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desvenlafaxine succinate for the treatment of major depressive disorder.
    Lohoff FW; Rickels K
    Expert Opin Pharmacother; 2008 Aug; 9(12):2129-36. PubMed ID: 18671467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
    Béïque JC; de Montigny C; Blier P; Debonnel G
    Synapse; 1999 Jun; 32(3):198-211. PubMed ID: 10340630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats.
    Perry KW; Fuller RW
    J Neural Transm (Vienna); 1997; 104(8-9):953-66. PubMed ID: 9451727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
    Beyer CE; Boikess S; Luo B; Dawson LA
    J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin-norepinephrine reuptake inhibitor.
    Nichols AI; Tourian KA; Tse SY; Paul J
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1565-74. PubMed ID: 21067460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of the dual mechanisms of action of venlafaxine.
    Harvey AT; Rudolph RL; Preskorn SH
    Arch Gen Psychiatry; 2000 May; 57(5):503-9. PubMed ID: 10807491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1813-22. PubMed ID: 10884562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characterization of PA01, a novel promising triple reuptake inhibitor.
    Hou J; Xing Y; Zuo D; Wu Y; Tian J; Meng Q; Yang M
    Physiol Behav; 2015 Jan; 138():141-9. PubMed ID: 25447484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.